NCT04586530View on ClinicalTrials.gov

Telehealth and Memory Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Chemotherapy-related Cognitive Dysfunction
Interventions
BEHAVIORAL

Memory and Attention Adaptation Training (MAAT)

A cognitive-behavioral therapy (CBT) for treatment of chemotherapy-related cognitive dysfunction (CRCD) among cancer survivors.

BEHAVIORAL

Supportive Therapy (ST)

Standard attention control condition therapy for treatment of chemotherapy-related cognitive dysfunction (CRCD) among cancer survivors.

Trial Locations (2)

15232

UPMC Hillman Cancer Center, Pittsburgh

46202

Indiana University, Indianapolis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pittsburgh

OTHER